Lambert René
René Lambert, World Health Organization International Agency for Research on Cancer, Screening Group, Lyon 69372, France.
World J Gastrointest Endosc. 2012 Dec 16;4(12):518-25. doi: 10.4253/wjge.v4.i12.518.
The aim of this study is to describe the role of endoscopy in detection and treatment of neoplastic lesions of the digestive mucosa in asymptomatic persons. Esophageal squamous cell cancer occurs in relation to nutritional deficiency and alcohol or tobacco consumption. Esophageal adenocarcinoma develops in Barrett's esophagus, and stomach cancer in chronic gastric atrophy with Helicobacter pylori infection. Colorectal cancer is favoured by a high intake in calories, excess weight, low physical activity. In opportunistic or individual screening endoscopy is the primary detection procedure offered to an asymptomatic individual. In organized or mass screening proposed by National Health Authorities to a population, endoscopy is performed only in persons found positive to a filter selection test. The indications of primary upper gastrointestinal endoscopy and colonoscopy in opportunistic screening are increasingly developing over the world. Organized screening trials are proposed in some regions of China at high risk for esophageal cancer; the selection test is cytology of a balloon or sponge scrapping; they are proposed in Japan for stomach cancer with photofluorography as a selection test; and in Europe, America and Japan; for colorectal cancer with the fecal occult blood test as a selection test. Organized screening trials in a country require an evaluation: the benefit of the intervention assessed by its impact on incidence and on the 5 year survival for the concerned tumor site; in addition a number of bias interfering with the evaluation have to be controlled. Drawbacks of screening are in the morbidity of the diagnostic and treatment procedures and in overdetection of none clinically relevant lesions. The strategy of endoscopic screening applies to early cancer and to benign adenomatous precursors of adenocarcinoma. Diagnostic endoscopy is conducted in 2 steps: at first detection of an abnormal area through changes in relief, in color or in the course of superficial capillaries; then characterization of the morphology of the lesion according to the Paris classification and prediction of the risk of malignancy and depth of invasion, with the help of chromoscopy, magnification and image processing with neutrophil bactericidal index or FICE. Then treatment decision offers 3 options according to histologic prediction: abstention, endoscopic resection, surgery. The rigorous quality control of endoscopy will reduce the miss rate of lesions and the occurrence of interval cancer.
本研究的目的是描述内镜检查在无症状人群消化黏膜肿瘤性病变检测和治疗中的作用。食管鳞状细胞癌的发生与营养缺乏以及酒精或烟草消费有关。食管腺癌在巴雷特食管中发展,而胃癌在伴有幽门螺杆菌感染的慢性胃萎缩中发生。结直肠癌则因高热量摄入、超重、低体力活动而更易发生。在机会性或个体筛查中,内镜检查是提供给无症状个体的主要检测方法。在国家卫生当局针对人群进行的有组织或大规模筛查中,仅对经筛选试验呈阳性的人进行内镜检查。在世界范围内,机会性筛查中初次上消化道内镜检查和结肠镜检查的适应证越来越多。在中国一些食管癌高危地区开展了有组织的筛查试验;筛选试验是球囊或海绵刮片细胞学检查;在日本针对胃癌开展了以荧光摄影作为筛选试验的筛查;在欧洲、美洲和日本,针对结直肠癌开展了以粪便潜血试验作为筛选试验的筛查。一个国家开展有组织的筛查试验需要进行评估:通过干预对相关肿瘤部位的发病率和5年生存率的影响来评估干预的益处;此外,还必须控制一些干扰评估的偏倚。筛查的缺点在于诊断和治疗程序的发病率以及对非临床相关病变的过度检测。内镜筛查策略适用于早期癌症和腺癌的良性腺瘤性前体。诊断性内镜检查分两步进行:首先通过隆起、颜色或浅表毛细血管走行的变化检测异常区域;然后根据巴黎分类法对病变形态进行特征描述,并借助染色内镜、放大以及中性粒细胞杀菌指数或智能电子分光染色法图像处理预测恶性风险和浸润深度。然后根据组织学预测,治疗决策提供三种选择:不治疗、内镜切除、手术。严格的内镜质量控制将降低病变漏诊率和间隔期癌的发生率。